@entity3190 and other associated metabolic factors, including @entity4854 , @entity2299 , @entity101 , and central @entity28 lead to increased cardiovascular risk and indicate a @entity209 . Levels of fasting @entity2690 were measured in an ethnic Gipsy minority group (n=149) and compared to the majority Slovak population (n=197). The average @entity2690 level was significantly increased in the minority group with a 21% risk value vs 5%. @entity4854 was equal in both groups (17% in Gipsy group, 16% in majority group). The incidence of other risk factors for @entity65 and @entity209 is greater in the Gipsy group (47% vs 38%--hypertriacylglycerolemia, 62% vs 46%--HDL- @entity165 level below safety limit, 16% vs 10%--systolic @entity101 , 20% vs 11%--diastolic @entity101 , 36% vs 22%-- @entity28 ). The results of @entity3190 , hypertriacylglycerolemia, @entity9680 , @entity101 and @entity28 indicate, that the Gipsy population is at higher risk for @entity65 . (Tab. 1, Fig. 1, Ref. 12.).

XXXX levels in Gipsy minority.

@entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity2299 :: ('MESH:D050171', 'Disease') :: ['dyslipidemia'] @entity9680 :: ('MESH:D052456', 'Disease') :: ['hypo-HDL-cholesterolemia'] @entity2690 :: ('3630', 'Gene') :: ['insulin'] @entity3190 :: ('MESH:D006946', 'Disease') :: ['Hyperinsulinemia', 'hyperinsulinemia'] @entity209 :: ('MESH:D008659', 'Disease') :: ['metabolic syndrome'] @entity4854 :: ('MESH:D006943', 'Disease') :: ['hyperglycemia', 'Hyperglycemia'] @entity65 :: ('MESH:D002318', 'Disease') :: ['cardiovascular disease'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity2690 :: (3630,Gene) :: ['Insulin']
